Business● LowOct 29 · Oct 29, 2026, 11:59 AM
Merck in charts: Keytruda hits $8.60B, Gardasil bounces back to $1.99B; pharma revenue climbs 4.2% Y/Y; animal health reaches $1.68B
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Merck's financial report shows Keytruda sales at $8.60 billion and Gardasil bouncing back to $1.99 billion, contributing to a 4.2% year-over-year increase in pharma revenue. The animal health division also achieved $1.68 billion, indicating strong performance across key segments.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business12m agoVitalHub reports Q3 resultsSeeking Alpha TechBusiness12m agoUnavailable products, delivery delays... The Ubaldi.com website is the subject of numerous customer complaintsBFMTV · FranceBusiness12m agoBiggest stock movers Friday: CBRS, FLO, and moreSeeking Alpha TechBusiness14m agoADARx Pharmaceuticals reports Q3 resultsSeeking Alpha Tech